TY - JOUR AU - Valean, S. AU - Acalovschi, M. AU - Diculescu, M. AU - Manuc, M. AU - Goldis, A. AU - Sfarti, C. PY - 2015 DA - 2015// TI - Mortality in Digestive Cancers, 2012: International Data and Data from Romania JO - J Gastrointestin Liver Dis VL - 24 UR - https://doi.org/10.15403/jgld.2014.1121.244.rom DO - 10.15403/jgld.2014.1121.244.rom ID - Valean2015 ER - TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2018 DA - 2018// TI - Cancer statistics, 2018 JO - CA Cancer J Clin VL - 68 UR - https://doi.org/10.3322/caac.21442 DO - 10.3322/caac.21442 ID - Siegel2018 ER - TY - JOUR AU - Torre, L. A. AU - Bray, F. AU - Siegel, R. L. AU - Ferlay, J. AU - Lortet-Tieulent, J. AU - Jemal, A. PY - 2015 DA - 2015// TI - Global cancer statistics, 2012 JO - CA Cancer J Clin VL - 65 UR - https://doi.org/10.3322/caac.21262 DO - 10.3322/caac.21262 ID - Torre2015 ER - TY - JOUR AU - Patru, C. L. AU - Surlin, V. AU - Georgescu, I. AU - Patru, E. PY - 2013 DA - 2013// TI - Current issues in gastric cancer epidemiology JO - Rev Med Chir Soc Med Nat Iasi VL - 117 ID - Patru2013 ER - TY - JOUR AU - Jomrich, G. AU - Schoppmann, S. F. PY - 2016 DA - 2016// TI - Targeted therapy in gastric cancer JO - Eur Surg VL - 48 UR - https://doi.org/10.1007/s10353-016-0389-1 DO - 10.1007/s10353-016-0389-1 ID - Jomrich2016 ER - TY - JOUR AU - Salati, M. AU - Orsi, G. AU - Smyth, E. AU - Aprile, G. AU - Beretta, G. AU - Vita, F. PY - 2019 DA - 2019// TI - Gastric cancer: translating novels concepts into clinical practice JO - Cancer Treat Rev VL - 79 UR - https://doi.org/10.1016/j.ctrv.2019.101889 DO - 10.1016/j.ctrv.2019.101889 ID - Salati2019 ER - TY - JOUR AU - Al-Batran, S. E. AU - Ducreux, M. AU - Ohtsu, A. PY - 2012 DA - 2012// TI - mTOR as a therapeutic target in patients with gastric cancer JO - Int J Cancer VL - 130 UR - https://doi.org/10.1002/ijc.26396 DO - 10.1002/ijc.26396 ID - Al-Batran2012 ER - TY - JOUR AU - Abdel-Maksoud, M. S. AU - El-Gamal, M. I. AU - Benhalilou, D. R. AU - Ashraf, S. AU - Mohammed, S. A. AU - Oh, C. H. PY - 2019 DA - 2019// TI - Mechanistic/mammalian target of rapamycin: recent pathological aspects and inhibitors JO - Med Res Rev VL - 39 UR - https://doi.org/10.1002/med.21535 DO - 10.1002/med.21535 ID - Abdel-Maksoud2019 ER - TY - JOUR AU - Yang, Q. AU - Guan, K. L. PY - 2007 DA - 2007// TI - Expanding mTOR signaling JO - Cell Res VL - 17 UR - https://doi.org/10.1038/cr.2007.64 DO - 10.1038/cr.2007.64 ID - Yang2007 ER - TY - JOUR AU - Kim, J. AU - Guan, K. L. PY - 2019 DA - 2019// TI - mTOR as a central hub of nutrient signalling and cell growth JO - Nat Cell Biol VL - 21 UR - https://doi.org/10.1038/s41556-018-0205-1 DO - 10.1038/s41556-018-0205-1 ID - Kim2019 ER - TY - JOUR AU - Shimobayashi, M. AU - Hall, M. N. PY - 2014 DA - 2014// TI - Making new contacts: the mTOR network in metabolism and signalling crosstalk JO - Nat Rev Mol Cell Biol. VL - 15 UR - https://doi.org/10.1038/nrm3757 DO - 10.1038/nrm3757 ID - Shimobayashi2014 ER - TY - JOUR AU - Peterson, R. T. AU - Beal, P. A. AU - Comb, M. J. AU - Schreiber, S. L. PY - 2000 DA - 2000// TI - FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.275.10.7416 DO - 10.1074/jbc.275.10.7416 ID - Peterson2000 ER - TY - JOUR AU - Zoncu, R. AU - Efeyan, A. AU - Sabatini, D. M. PY - 2011 DA - 2011// TI - mTOR: from growth signal integration to cancer, diabetes and ageing JO - Nat Rev Mol Cell Biol VL - 12 UR - https://doi.org/10.1038/nrm3025 DO - 10.1038/nrm3025 ID - Zoncu2011 ER - TY - JOUR AU - Fenton, T. R. AU - Gout, I. T. PY - 2011 DA - 2011// TI - Functions and regulation of the 70kDa ribosomal S6 kinases JO - Int J Biochem Cell Biol VL - 43 UR - https://doi.org/10.1016/j.biocel.2010.09.018 DO - 10.1016/j.biocel.2010.09.018 ID - Fenton2011 ER - TY - JOUR AU - Bellacosa, A. AU - Kumar, C. C. AU - Cristofano, A. AU - Testa, J. R. PY - 2005 DA - 2005// TI - Activation of AKT kinases in cancer: implications for therapeutic targeting JO - Adv Cancer Res VL - 94 UR - https://doi.org/10.1016/S0065-230X(05)94002-5 DO - 10.1016/S0065-230X(05)94002-5 ID - Bellacosa2005 ER - TY - JOUR AU - Manning, B. D. AU - Toker, A. PY - 2017 DA - 2017// TI - AKT/PKB signaling: navigating the network JO - Cell. VL - 169 UR - https://doi.org/10.1016/j.cell.2017.04.001 DO - 10.1016/j.cell.2017.04.001 ID - Manning2017 ER - TY - JOUR AU - Zhang, Y. AU - Kwok-Shing Ng, P. AU - Kucherlapati, M. AU - Chen, F. AU - Liu, Y. AU - Tsang, Y. H. PY - 2017 DA - 2017// TI - A Pan-Cancer Proteogenomic atlas of PI3K/AKT/mTOR pathway alterations JO - Cancer Cell VL - 31 UR - https://doi.org/10.1016/j.ccell.2017.04.013 DO - 10.1016/j.ccell.2017.04.013 ID - Zhang2017 ER - TY - JOUR AU - Riquelme, I. AU - Tapia, O. AU - Espinoza, J. A. AU - Leal, P. AU - Buchegger, K. AU - Sandoval, A. PY - 2016 DA - 2016// TI - The gene expression status of the PI3K/AKT/mTOR pathway in gastric Cancer tissues and cell lines JO - Pathol Oncol Res VL - 22 UR - https://doi.org/10.1007/s12253-016-0066-5 DO - 10.1007/s12253-016-0066-5 ID - Riquelme2016 ER - TY - JOUR AU - Farran, B. AU - Muller, S. AU - Montenegro, R. C. PY - 2017 DA - 2017// TI - Gastric cancer management: kinases as a target therapy JO - Clin Exp Pharmacol Physiol VL - 44 UR - https://doi.org/10.1111/1440-1681.12743 DO - 10.1111/1440-1681.12743 ID - Farran2017 ER - TY - JOUR AU - O'Reilly, K. E. AU - Rojo, F. AU - She, Q. B. AU - Solit, D. AU - Mills, G. B. AU - Smith, D. PY - 2006 DA - 2006// TI - mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-2925 DO - 10.1158/0008-5472.CAN-05-2925 ID - O'Reilly2006 ER - TY - JOUR AU - Ohtsu, A. AU - Ajani, J. A. AU - Bai, Y. X. AU - Bang, Y. J. AU - Chung, H. C. AU - Pan, H. M. PY - 2013 DA - 2013// TI - Everolimus for previously treated advanced gastric cancer: results of the randomized, double-blind, phase III GRANITE-1 study JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.48.3552 DO - 10.1200/JCO.2012.48.3552 ID - Ohtsu2013 ER - TY - JOUR AU - Peddi, V. R. AU - Wiseman, A. AU - Chavin, K. AU - Slakey, D. PY - 2013 DA - 2013// TI - Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation JO - Transplant Rev (Orlando) VL - 27 UR - https://doi.org/10.1016/j.trre.2013.06.001 DO - 10.1016/j.trre.2013.06.001 ID - Peddi2013 ER - TY - JOUR AU - Zhang, K. AU - Dai, H. AU - Liang, W. AU - Zhang, L. AU - Deng, Z. PY - 2019 DA - 2019// TI - Fermented dairy foods intake and risk of cancer JO - Int J Cancer VL - 144 UR - https://doi.org/10.1002/ijc.31959 DO - 10.1002/ijc.31959 ID - Zhang2019 ER - TY - JOUR AU - Mueller, T. AU - Jordan, K. AU - Voigt, W. PY - 2011 DA - 2011// TI - Promising cytotoxic activity profile of fermented wheat germ extract (Avemar(R)) in human cancer cell lines JO - J Exp Clin Cancer Res VL - 30 UR - https://doi.org/10.1186/1756-9966-30-42 DO - 10.1186/1756-9966-30-42 ID - Mueller2011 ER - TY - JOUR AU - Zu, X. AU - Xie, X. AU - Zhang, Y. AU - Liu, K. AU - Bode, A. M. AU - Dong, Z. PY - 2019 DA - 2019// TI - Lapachol is a novel ribosomal protein S6 kinase 2 inhibitor that suppresses growth and induces intrinsic apoptosis in esophageal squamous cell carcinoma cells JO - Phytother Res VL - 33 UR - https://doi.org/10.1002/ptr.6415 DO - 10.1002/ptr.6415 ID - Zu2019 ER - TY - JOUR AU - Lu, J. J. AU - Bao, J. L. AU - Wu, G. S. AU - Xu, W. S. AU - Huang, M. Q. AU - Chen, X. P. PY - 2013 DA - 2013// TI - Quinones derived from plant secondary metabolites as anti-cancer agents JO - Anti Cancer Agents Med Chem VL - 13 ID - Lu2013 ER - TY - JOUR AU - Kamiya, T. AU - Tanimoto, Y. AU - Fujii, N. AU - Negishi, T. AU - Suzuki, T. AU - Hatano, T. PY - 2018 DA - 2018// TI - 2,6-Dimethoxy-1,4-benzoquinone, isolation and identification of anti-carcinogenic, anti-mutagenic and anti-inflammatory component from the juice of Vitis coignetiae JO - Food Chem Toxicol VL - 122 UR - https://doi.org/10.1016/j.fct.2018.10.028 DO - 10.1016/j.fct.2018.10.028 ID - Kamiya2018 ER - TY - JOUR AU - Hay, N. AU - Sonenberg, N. PY - 2004 DA - 2004// TI - Upstream and downstream of mTOR JO - Genes Dev VL - 18 UR - https://doi.org/10.1101/gad.1212704 DO - 10.1101/gad.1212704 ID - Hay2004 ER - TY - JOUR AU - Kawada, J. AU - Ito, Y. AU - Iwata, S. AU - Suzuki, M. AU - Kawano, Y. AU - Kanazawa, T. PY - 2014 DA - 2014// TI - mTOR inhibitors induce cell-cycle arrest and inhibit tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cells JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-3172 DO - 10.1158/1078-0432.CCR-13-3172 ID - Kawada2014 ER - TY - JOUR AU - Sia, D. AU - Moeini, A. AU - Labgaa, I. AU - Villanueva, A. PY - 2015 DA - 2015// TI - The future of patient-derived tumor xenografts in cancer treatment JO - Pharmacogenomics. VL - 16 UR - https://doi.org/10.2217/pgs.15.102 DO - 10.2217/pgs.15.102 ID - Sia2015 ER - TY - JOUR AU - Hidalgo, M. AU - Amant, F. AU - Biankin, A. V. AU - Budinska, E. AU - Byrne, A. T. AU - Caldas, C. PY - 2014 DA - 2014// TI - Patient-derived xenograft models: an emerging platform for translational cancer research JO - Cancer discovery VL - 4 UR - https://doi.org/10.1158/2159-8290.CD-14-0001 DO - 10.1158/2159-8290.CD-14-0001 ID - Hidalgo2014 ER - TY - JOUR AU - Hutchinson, L. AU - Kirk, R. PY - 2011 DA - 2011// TI - High drug attrition rates--where are we going wrong? JO - Nat Rev Clin Oncol VL - 8 UR - https://doi.org/10.1038/nrclinonc.2011.34 DO - 10.1038/nrclinonc.2011.34 ID - Hutchinson2011 ER - TY - JOUR AU - Siolas, D. AU - Hannon, G. J. PY - 2013 DA - 2013// TI - Patient-derived tumor xenografts: transforming clinical samples into mouse models JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-13-1069 DO - 10.1158/0008-5472.CAN-13-1069 ID - Siolas2013 ER - TY - JOUR AU - Xiao, L. AU - Wang, Y. C. AU - Li, W. S. AU - Du, Y. PY - 2009 DA - 2009// TI - The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray JO - J Exp Clin Cancer Res VL - 28 UR - https://doi.org/10.1186/1756-9966-28-152 DO - 10.1186/1756-9966-28-152 ID - Xiao2009 ER - TY - JOUR AU - An, J. Y. AU - Kim, K. M. AU - Choi, M. G. AU - Noh, J. H. AU - Sohn, T. S. AU - Bae, J. M. PY - 2010 DA - 2010// TI - Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer JO - Int J Cancer VL - 126 UR - https://doi.org/10.1002/ijc.24872 DO - 10.1002/ijc.24872 ID - An2010 ER - TY - JOUR AU - Chen, J. S. AU - Wang, Q. AU - Fu, X. H. AU - Huang, X. H. AU - Chen, X. L. AU - Cao, L. Q. PY - 2009 DA - 2009// TI - Involvement of PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in hepatocellular carcinoma: association with MMP-9 JO - Hepatol Res VL - 39 UR - https://doi.org/10.1111/j.1872-034X.2008.00449.x DO - 10.1111/j.1872-034X.2008.00449.x ID - Chen2009 ER - TY - JOUR AU - Qian, Z. R. AU - Ter-Minassian, M. AU - Chan, J. A. AU - Imamura, Y. AU - Hooshmand, S. M. AU - Kuchiba, A. PY - 2013 DA - 2013// TI - Prognostic significance of MTOR pathway component expression in neuroendocrine tumors JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.46.6946 DO - 10.1200/JCO.2012.46.6946 ID - Qian2013 ER - TY - JOUR AU - Yanai, A. AU - Inoue, N. AU - Yagi, T. AU - Nishimukai, A. AU - Miyagawa, Y. AU - Murase, K. PY - 2015 DA - 2015// TI - Activation of mTOR/S6K but not MAPK pathways might be associated with high Ki-67, ER(+), and HER2(−) breast Cancer JO - Clin Breast Cancer VL - 15 UR - https://doi.org/10.1016/j.clbc.2014.12.002 DO - 10.1016/j.clbc.2014.12.002 ID - Yanai2015 ER - TY - JOUR AU - Cloughesy, T. F. AU - Yoshimoto, K. AU - Nghiemphu, P. AU - Brown, K. AU - Dang, J. AU - Zhu, S. PY - 2008 DA - 2008// TI - Antitumor activity of rapamycin in a phase I trial for patients with recurrent PTEN-deficient glioblastoma JO - PLoS Med VL - 5 UR - https://doi.org/10.1371/journal.pmed.0050008 DO - 10.1371/journal.pmed.0050008 ID - Cloughesy2008 ER -